Notably, downregulation of miR-149, targeted by lncRNA PCAT-1, has been documented to have the capacity of reversing the inhibitory effects of downregulated lncRNA PCAT-1 on CRC cell growth [15]. This evidence concerns the gene PCAT1 and colorectal carcinoma.